Pictet Asset Management Holding Sa Kiniksa Pharmaceuticals, Ltd. Transaction History

Pictet Asset Management Holding Sa

  • $85.6 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$17.63 - $21.74 $1.94 Million - $2.4 Million
-110,183 Reduced 7.01%
1,460,633 $28.8 Million
Q4 2023

Feb 13, 2024
SELL
$14.37 - $19.07 $487,157 - $646,492
-33,901 Reduced 2.11%
1,570,816 $27.6 Million
Q3 2023

Nov 14, 2023
BUY
$13.62 - $20.2 $21.9 Million - $32.4 Million
1,604,717 New
1,604,717 $27.9 Million

Others Institutions Holding KNSA

# of Institutions
11
Shares Held
1.89M
Call Options Held
0
Put Options Held
0
View Full List

About Kiniksa Pharmaceuticals, Ltd.

KNSA Quotes by TradingView
  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $862M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Pictet Asset Management Holding Sa Portfolio

Follow Pictet Asset Management Holding Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Holding Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Holding Sa with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email